   #alternate alternate Bioaster Â» Feed Bioaster Â» Comments Feed Bioaster
   Â» iCal Feed

   Bioaster Bioaster
   (BUTTON) ____________________
   Join usContact us
     * en en
     * fr fr

   (BUTTON) Menu

     * BIOASTER
          + In a nutshell
          + A new collaborative model
               o Organisation & Special support
          + Mission Vision Values
          + BIOASTER Community
               o Founders
               o FIT Association
               o Governance
               o Management
          + HR
          + Partnerships
          + Infrastructures
     * Disrupting healthcare
       through collaboration
          + De-risking innovation
          + For whom?
          + Meet our business team
          + Security & Quality
          + ISO 9001 certficate
     * Technology Innovations
       in microbiology & infectiology
          + News
          + Fields of applications
               o Microbiota
               o Diagnostic
               o Antimicrobials
               o Vaccines
          + Unique technology value chain
               o Technologies designed by BIOASTER
               o Expertises @ BIOASTER
          + Scientific & Technology experts
          + Equipment
     * Projects, Partners
       & Publications
          + Partners
          + Collaborative projects examples
          + EU Projects
          + Publications
          + Posters
     * News, events & PR
          + Events
          + Press releases & contacts

     * Transforming Technologies
       Transforming technologies
     * Disrupting Healthcare
       Disrupting Healthcare
       Disrupting
       Healthcare
     * Derisking Innovation
       De-risking Innovation

   Latest news
   Registration opens to the 3rd I4ID 2019 congress
   Registration in now open to the 3rd Immunotherapies & Innovation for
   Infectious Diseases (I4ID2019) that will be held on December 4-5, 2019
   in Lyon, France. https://i4id.org/register/ The purpose of these
   two-day congress, jointly organized by @BIOASTER, @MabDesign and
   @LyonbiopÃ´le , is to foster interactions between pharmaceutical
   industries, research labs, service...
   read more +

   Zoom
   New video on line about BIOFILM: a major issue on public healthcare
   This video is intended to explain to everyone what the #biofilm is and
   why it is a key element to improve research, in addition, in...
   read more +

   Live
   25/092019
   New video on line about BIOFILM:...
   read more
   13/092019
   Join us @FLI congress
   read more
   09/092019
   Registration opens to the 3rd I4ID...
   read more
   30/082019
   Rapprochement stratÃ©gique entre #MÃ©taGÃ©noPolis (MGP) et...
   read more
   01/082019
   GNA NOW kicks off its battle...
   read more
   +See all

The first Innovation & Technology
Institute in Microbiology

   Violet Violet
   Technologies designed by BIOASTER
   Jaune Jaune
   Disrupting healthcare
   Bleu Bleu
   Technologies overview
   Orange Orange
   Scientific & technology experts
   Rouge Rouge
   Projects, Partners & Publications

   BIOASTER, the first Technology Innovation Institute in Microbiology
   To maximise and add value to innovative projects,with private and
   public partners, for global health issues.
   BIOASTER â€“ Headquarters
   40 Avenue Tony Garnier
   69007 Lyon (France)
   Phone : +33 (0)4 69 84 26 00
   Fax : 33(0)4 69 84 25 80
   BIOASTER Paris
   BÃ¢timent F. Jacob
   28 rue du docteur Roux
   75015 Paris (France)
   TÃ©l : +33 (0)4 69 84 26 00
   Fax : 33 (0)1 40 61 38 88
   Investir l'avenir Investir l'avenir

   BIOASTER Copyright Â© 2019
   Contact usSite mapLegal noticeMentions lÃ©gales

   By continuing browsing this website, you accept the use of cookies or
   other tracers for statistics of visits to optimize the functionality of
   the site, and or privacy policy. Accept Reject Read More

   Privacy & Cookies Policy

   (BUTTON)

   Necessary Always Enabled
   #alternate alternate Bioaster Â» Flux Bioaster Â» Flux des commentaires
   Bioaster Â» Flux iCal

   Bioaster Bioaster
   (BUTTON) ____________________
   Rejoignez-nousContactez-nous
     * en en
     * fr fr

   (BUTTON) Menu

     * BIOASTER
          + Lâ€™essentiel
          + Un nouveau modÃ¨le collaboratif
               o Organisation et support
          + Vision Mission Valeurs
          + CommunautÃ© BIOASTER
               o Fondateurs
               o Lâ€™Association FIT
               o Gouvernance
               o Management
          + Ressources Humaines
          + Partenariats
          + Infrastructures
     * Disrupter la santÃ©
       par la collaboration
          + DÃ©-risquer lâ€™innovation
          + Pour qui ?
          + Rencontrez notre Ã©quipe partenariats et dÃ©veloppement
          + SÃ©curitÃ© & QualitÃ©
          + Certification ISO 9001
     * Innovations technologiques en
       microbiologie et en infectiologie
          + ActualitÃ©s
          + Domaines dâ€™applications
               o Programme Vaccins
               o Programme Microbiote
               o Programme Antimicrobiens
               o Programme Diagnostic
          + Une chaine de valeur technologique unique
               o Les technologies Â« designed by Â» BIOASTER
               o Expertises @ BIOASTER
          + Experts science et technologie
          + Equipements
     * RÃ©fÃ©rences Projets
       et publications
          + Partenaires
          + Exemples de projets collaboratifs
          + Projets europÃ©ens
          + Publications
          + Posters
     * ActualitÃ©s, Ã©vÃ©nements,
       publications de presse
          + Ã‰vÃ©nements
          + CommuniquÃ© de presse & contact

     * Transforming Technologies
       Technologies transformantes
     * Disrupting Healthcare
       Disrupter la santÃ©
       Disrupting
       Healthcare
     * Derisking Innovation
       DÃ©-risquer lâ€™innovation

   Ã€ la une
   Les inscriptions sont ouvertes pour le 3Ã¨me congrÃ¨s I4ID 2019
   Les inscriptions pour la 3Ã¨me Ã©dition du Programme ImmunothÃ©rapie et
   Innovation pour les maladies infectieuses (I4ID2019) auront lieu les 4
   et 5 dÃ©cembre 2019 Ã  Lyon, en France. https://i4id.org/register/ Ce
   congrÃ¨s de deux jours, organisÃ© conjointement par @BIOASTER, @MabDesign
   et @ LyonbiopÃ´le, a pour objectif de favoriser les interactions
   entre...
   en savoir plus +

   Zoom
   Biofilm â€“ Un enjeu majeur de santÃ© publique BIOASTER
   Le biofilm est un problÃ¨me majeur de santÃ© publique. Cette vidÃ©o, a
   pour but dâ€™expliquer Ã  tous ce quâ€™est le biofilm et pourquoi il est...
   en savoir plus +

   Live
   25/092019
   Biofilm â€“ Un enjeu majeur de...
   en savoir plus
   09/092019
   Les inscriptions sont ouvertes pour le...
   en savoir plus
   18/072019
   BIOASTER et Pherecydes Pharma sâ€™associent pour...
   en savoir plus
   +Voir tout

Le premier Institut dâ€™Innovation
Technologique en Microbiologie

   Violet Violet
   Les technologies Â« designed by Â» BIOASTER
   Jaune Jaune
   Disrupter la santÃ©
   Bleu Bleu
   Cartes des technologies
   Orange Orange
   Nos experts scientifiques
   Rouge Rouge
   RÃ©fÃ©rences, projets & publications

   BIOASTER, le premier Institut dâ€™Innovation Technologique en
   Microbiologie.
   Favoriser, accÃ©lÃ©rer et apporter une nouvelle valeur ajoutÃ©e aux
   projets collaboratifs, avec des partenaires publics et privÃ©s, pour
   mieux rÃ©pondre aux enjeux de santÃ© globale.
   BIOASTER â€“ SiÃ¨ge social
   40 Avenue Tony Garnier
   69007 Lyon (France)
   Phone : +33 (0)4 69 84 26 00
   Fax : 33(0)4 69 84 25 80
   BIOASTER Paris
   BÃ¢timent F. Jacob
   28 rue du docteur Roux
   75015 Paris (France)
   TÃ©l : +33 (0)4 69 84 26 00
   Fax : 33 (0)1 40 61 38 88
   Investir l'avenir Investir l'avenir

   BIOASTER Copyright Â© 2019
   Contactez-nousPlan du siteMentions lÃ©gales

   By continuing browsing this website, you accept the use of cookies or
   other tracers for statistics of visits to optimize the functionality of
   the site, and or privacy policy. Accept Reject Read More

   Privacy & Cookies Policy

   (BUTTON)

   NÃ©cessaire Toujours activÃ©


   #alternate alternate Bioaster Â» Feed Bioaster Â» Comments Feed Bioaster
   Â» iCal Feed

   Bioaster Bioaster
   (BUTTON) ____________________
   Join usContact us
     * en en
     * fr fr

   (BUTTON) Menu

     * BIOASTER
          + In a nutshell
          + A new collaborative model
               o Organisation & Special support
          + Mission Vision Values
          + BIOASTER Community
               o Founders
               o FIT Association
               o Governance
               o Management
          + HR
          + Partnerships
          + Infrastructures
     * Disrupting healthcare
       through collaboration
          + De-risking innovation
          + For whom?
          + Meet our business team
          + Security & Quality
          + ISO 9001 certficate
     * Technology Innovations
       in microbiology & infectiology
          + News
          + Fields of applications
               o Microbiota
               o Diagnostic
               o Antimicrobials
               o Vaccines
          + Unique technology value chain
               o Technologies designed by BIOASTER
               o Expertises @ BIOASTER
          + Scientific & Technology experts
          + Equipment
     * Projects, Partners
       & Publications
          + Partners
          + Collaborative projects examples
          + EU Projects
          + Publications
          + Posters
     * News, events & PR
          + Events
          + Press releases & contacts

     * Transforming Technologies
       Transforming technologies
     * Disrupting Healthcare
       Disrupting Healthcare
       Disrupting
       Healthcare
     * Derisking Innovation
       De-risking Innovation

   Latest news
   Registration opens to the 3rd I4ID 2019 congress
   Registration in now open to the 3rd Immunotherapies & Innovation for
   Infectious Diseases (I4ID2019) that will be held on December 4-5, 2019
   in Lyon, France. https://i4id.org/register/ The purpose of these
   two-day congress, jointly organized by @BIOASTER, @MabDesign and
   @LyonbiopÃ´le , is to foster interactions between pharmaceutical
   industries, research labs, service...
   read more +

   Zoom
   New video on line about BIOFILM: a major issue on public healthcare
   This video is intended to explain to everyone what the #biofilm is and
   why it is a key element to improve research, in addition, in...
   read more +

   Live
   25/092019
   New video on line about BIOFILM:...
   read more
   13/092019
   Join us @FLI congress
   read more
   09/092019
   Registration opens to the 3rd I4ID...
   read more
   30/082019
   Rapprochement stratÃ©gique entre #MÃ©taGÃ©noPolis (MGP) et...
   read more
   01/082019
   GNA NOW kicks off its battle...
   read more
   +See all

The first Innovation & Technology
Institute in Microbiology

   Violet Violet
   Technologies designed by BIOASTER
   Jaune Jaune
   Disrupting healthcare
   Bleu Bleu
   Technologies overview
   Orange Orange
   Scientific & technology experts
   Rouge Rouge
   Projects, Partners & Publications

   BIOASTER, the first Technology Innovation Institute in Microbiology
   To maximise and add value to innovative projects,with private and
   public partners, for global health issues.
   BIOASTER â€“ Headquarters
   40 Avenue Tony Garnier
   69007 Lyon (France)
   Phone : +33 (0)4 69 84 26 00
   Fax : 33(0)4 69 84 25 80
   BIOASTER Paris
   BÃ¢timent F. Jacob
   28 rue du docteur Roux
   75015 Paris (France)
   TÃ©l : +33 (0)4 69 84 26 00
   Fax : 33 (0)1 40 61 38 88
   Investir l'avenir Investir l'avenir

   BIOASTER Copyright Â© 2019
   Contact usSite mapLegal noticeMentions lÃ©gales

   By continuing browsing this website, you accept the use of cookies or
   other tracers for statistics of visits to optimize the functionality of
   the site, and or privacy policy. Accept Reject Read More

   Privacy & Cookies Policy

   (BUTTON)

   Necessary Always Enabled
    https://www.bioaster.org/?lang=fr Microbiology Technology Institute
   Fri, 27 Sep 2019 09:00:46 +0000 fr-FR hourly 1
   https://wordpress.org/?v=5.2.3
   https://www.bioaster.org/biofilm-un-enjeu-majeur-de-sante-publique-bioa
   ster/?lang=fr Wed, 25 Sep 2019 15:34:14 +0000 emilie.bernard BIOASTER
   événements BIOASTER technologies L'institut BIOASTER Vidéos Zoom
   https://www.bioaster.org/?p=2062 Le biofilm est un problème majeur de
   santé publique. Cette vidéo, a pour but d™expliquer à tous ce qu™est le
   biofilm et pourquoi il est un élément clef pour améliorer les
   recherches, en autre, dans la lutte contre les maladies chroniques et
   la résistance bactérienne aux antibiotiques. Avec ses partenaires,
   BIOASTER développe des technologies capables [&#8230;]
   https://www.bioaster.org/les-inscriptions-sont-ouvertes-pour-le-3eme-co
   ngres-i4id-2019/?lang=fr Mon, 09 Sep 2019 09:47:06 +0000 emilie.bernard
   BIOASTER événements Congrès / conférences Dernières actualités
   Événements @BIOASTER L'institut BIOASTER Live
   https://www.bioaster.org/les-inscriptions-sont-ouvertes-pour-le-3eme-co
   ngres-i4id-2019/ Les inscriptions pour la 3ème édition du Programme
   Immunothérapie et Innovation pour les maladies infectieuses (I4ID2019)
   auront lieu les 4 et 5 décembre 2019 à Lyon, en France.
   https://i4id.org/register/ Ce congrès de deux jours, organisé
   conjointement par @BIOASTER, @MabDesign et @ Lyonbiopôle, a pour
   objectif de favoriser les interactions entre les industries
   pharmaceutiques, les laboratoires [&#8230;]
   https://www.bioaster.org/bioaster-et-pherecydes-pharma-sassocient-pour-
   explorer-lutilisation-du-traitement-par-phage-pour-traiter-les-infectio
   ns-compliquees-des-voies-urinaires/?lang=fr Thu, 18 Jul 2019 09:48:40
   +0000 emilie.bernard BIOASTER partenaires Projets Zoom
   https://www.bioaster.org/bioaster-et-pherecydes-pharma-sassocient-pour-
   explorer-lutilisation-du-traitement-par-phage-pour-traiter-les-infectio
   ns-compliquees-des-voies-urinaires/ BIOASTER a annoncé la signature
   d&#8217;un accord de collaboration avec Pherecydes Pharma, une société
   française de biotechnologie, dans le but de découvrir des
   bactériophages lytiques, qui sera développé en une solution
   pharmaceutique pour traiter les infections bactériennes, y compris
   celles causées par des souches multirésistantes. Ce projet, appelé
   PhagUTI, représente une occasion unique pour les [&#8230;]
